All Relations between Depression and serotonin

Publication Sentence Publish Date Extraction Date Species
Young-Min Park, Yeon-Kyung Jun. Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 4. 2010-07-30. PMID:20298736. manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression. 2010-07-30 2023-08-12 Not clear
Gregory F Oxenkru. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Annals of the New York Academy of Sciences. vol 1199. 2010-07-29. PMID:20633104. diminished serotonin production is associated with mental depression while increased formation of kynurenines might contribute to development of mets/aand via their apoptotic, neurotoxic, and pro-oxidative effects, and upregulation of inducible nitric oxide synthase, phospholipase a2, arachidonic acid, prostaglandin, 5-lipoxygenase, and leukotriene cascade. 2010-07-29 2023-08-12 Not clear
Ixchel Herrera-Guzmán, Esteve Gudayol-Ferré, Jorge E Herrera-Abarca, Daniel Herrera-Guzmán, Pedro Montelongo-Pedraza, Ferran Padrós Blázquez, Maribel Peró-Cebollero, Joan Guàrdia-Olmo. Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. Journal of affective disorders. vol 123. issue 1-3. 2010-07-26. PMID:19896719. major depressive disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with major depressive disorder in recovery. 2010-07-26 2023-08-12 Not clear
R R Tagirova, A Kh Timoshenko, Kh L Gainutdinov, M B Shtark, O I Epshtei. Serotonin precursor 5-hydroxytryptophan disturbs the protective effect of low doses of antibodies to S100B protein during the formation of long-term sensitization. Bulletin of experimental biology and medicine. vol 148. issue 3. 2010-07-26. PMID:20396741. we studied the effect of ultralow doses of antibodies to calcium-binding protein s-100b and 5-hydroxytryptophan, a metabolic precursor of serotonin, on the formation of long-term sensitization as a neurobiological model of anxiety and depression. 2010-07-26 2023-08-12 Not clear
Sandeep Shrivastava, Thomas J Pucadyil, Yamuna Devi Paila, Sourav Ganguly, Amitabha Chattopadhya. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors. Biochemistry. vol 49. issue 26. 2010-07-21. PMID:20521763. our results assume significance in view of recent reports highlighting the symptoms of anxiety and depression in humans upon statin administration, and the role of serotonin(1a) receptors in anxiety and depression. 2010-07-21 2023-08-12 human
Jeffery N Talbot, Emily M Jutkiewicz, Steven M Graves, Crystal F Clemans, Melanie R Nicol, Richard M Mortensen, Xinyan Huang, Richard R Neubig, John R Trayno. RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects. Proceedings of the National Academy of Sciences of the United States of America. vol 107. issue 24. 2010-07-14. PMID:20534514. elevating serotonin (5-ht) levels with selective serotonin reuptake inhibitors (ssris) is the most widely used treatment for depression. 2010-07-14 2023-08-12 mouse
Maxwell R Bennet. Synapse regression in depression: the role of 5-HT receptors in modulating NMDA receptor function and synaptic plasticity. The Australian and New Zealand journal of psychiatry. vol 44. issue 4. 2010-07-13. PMID:20307163. synapse regression in depression: the role of 5-ht receptors in modulating nmda receptor function and synaptic plasticity. 2010-07-13 2023-08-12 human
Tiffany Fiel. Prenatal depression and selective serotonin reuptake inhibitors. The International journal of neuroscience. vol 120. issue 3. 2010-07-13. PMID:20374082. prenatal depression and selective serotonin reuptake inhibitors. 2010-07-13 2023-08-12 Not clear
Andrea Bari, David E Theobald, Daniele Caprioli, Adam C Mar, Alex Aidoo-Micah, Jeffrey W Dalley, Trevor W Robbin. Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 6. 2010-07-12. PMID:20107431. these results parallel some of the findings in humans on effects of 5-ht manipulations and are relevant to hypotheses of altered response to feedback in depression. 2010-07-12 2023-08-12 rat
Thomas Frodl, Elena Reinhold, Nikolaos Koutsouleris, Gary Donohoe, Brigitta Bondy, Maximilian Reiser, Hans-Jürgen Möller, Eva M Meisenzah. Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 6. 2010-07-12. PMID:20147891. childhood stress, serotonin transporter gene and brain structures in major depression. 2010-07-12 2023-08-12 human
Willem Heydendael, Lauren Jacobso. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice. The European journal of neuroscience. vol 31. issue 5. 2010-07-12. PMID:20374287. however, selective serotonin reuptake inhibitors (ssris) are reported to be effective in both melancholic and atypical depression. 2010-07-12 2023-08-12 mouse
Naoki Oishi, Sho Kanzaki, Seiichi Shinden, Hideyuki Saito, Yasuhiro Inoue, Kaoru Ogaw. Effects of selective serotonin reuptake inhibitor on treating tinnitus in patients stratified for presence of depression or anxiety. Audiology & neuro-otology. vol 15. issue 3. 2010-07-07. PMID:19851065. effects of selective serotonin reuptake inhibitor on treating tinnitus in patients stratified for presence of depression or anxiety. 2010-07-07 2023-08-12 Not clear
Naoki Oishi, Sho Kanzaki, Seiichi Shinden, Hideyuki Saito, Yasuhiro Inoue, Kaoru Ogaw. Effects of selective serotonin reuptake inhibitor on treating tinnitus in patients stratified for presence of depression or anxiety. Audiology & neuro-otology. vol 15. issue 3. 2010-07-07. PMID:19851065. we evaluated the effects of a selective serotonin reuptake inhibitor, paroxetine, on treating tinnitus.tinnitus patients stratified for the presence of depression and anxiety were studied retrospectively. 2010-07-07 2023-08-12 Not clear
Eva L van Donkelaar, Paul A T Kelly, Neil Dawson, Arjan Blokland, Jos Prickaerts, Harry W M Steinbusch, Linda Ferringto. Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebrovascular hyperperfusion in adult male Wistar rats. Journal of neuroscience research. vol 88. issue 7. 2010-06-30. PMID:19998482. the serotonergic (5-hydroxytryptamine; 5-ht) dysfunction found in depression may affect not only brain function (mood) but also cerebrovascular control. 2010-06-30 2023-08-12 rat
Susmita Parashar, Viola Vaccarin. Depression and CHD risk: how should we intervene? Current treatment options in cardiovascular medicine. vol 9. issue 4. 2010-06-29. PMID:17761112. safe and effective treatments of depression in patients with chd include cognitive behavior therapy and selective serotonin reuptake inhibitors. 2010-06-29 2023-08-12 Not clear
Xiaowei W Su, Xiao-Yuan Li, Mounira Banasr, Ronald S Duma. Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus. The international journal of neuropsychopharmacology. vol 12. issue 10. 2010-06-29. PMID:19775501. clinical research has shown that co-administration of eszopiclone, a sedative-hypnotic sleeping agent, and fluoxetine, a serotonin uptake inhibitor, exerts an additive antidepressant action in treating patients with both depression and insomnia. 2010-06-29 2023-08-12 rat
Tom Power, Robert Stewart, Marie-Laure Ancelin, Isabelle Jaussent, Alain Malafosse, Karen Ritchi. 5-HTTLPR genotype, stressful life events and late-life depression: no evidence of interaction in a French population. Neurobiology of aging. vol 31. issue 5. 2010-06-28. PMID:18640745. modification of the effect of life events on risk of depression by a polymorphism in the serotonin transporter gene promoter (5-httlpr) has been reported in child, adolescent, adult and elderly populations. 2010-06-28 2023-08-12 Not clear
Peter H Silverstone, Erica von Studnitz, Raimund Bulle. Current therapeutic strategies for anxious depressives. Expert review of neurotherapeutics. vol 3. issue 2. 2010-06-28. PMID:19810836. taken together, the results of published studies begin to suggest that patients with anxious depression may respond better to antidepressants that are dual action drugs (such as serotonin and noradrenaline re-uptake inhibitors), rather than single action drugs (such as specific serotonin re-uptake inhibitors). 2010-06-28 2023-08-12 Not clear
Greg L Clar. Mood disorders in patients with COPD: overview of current research and future needs. Expert review of neurotherapeutics. vol 3. issue 2. 2010-06-28. PMID:19810837. in this review, the theorectical relationship that exists between dopamine, serotonin and nicotine and how the biochemical nicotine dependence issues (with regard to mood) may actually be a key element in the understanding and treatment of depression later in the life of the development of chronic lung disease and depression, are discussed. 2010-06-28 2023-08-12 Not clear
Olivier Lambert, Michel Bouri. SNRIs: mechanism of action and clinical features. Expert review of neurotherapeutics. vol 2. issue 6. 2010-06-28. PMID:19810918. they are characterized by a mixed action on both major neuroamines of depression: norepinephrine and serotonin. 2010-06-28 2023-08-12 Not clear